Huai Zheng Peng
Vorstandsvorsitzender bei A&B (HK) Co. Ltd.
Profil
Huai Zheng Peng is currently the Chief Executive Officer at A&B (HK) Co. Ltd., Director at Neurelis, Inc., Director at Blueberry Therapeutics Ltd., Director at China Medical Venture Investment Hk Ltd., and Non-Executive Director at Cambridge United China Collaborations Ltd.
Previously, he held positions such as Director-Corporate Finance & Head-Life Sciences at Seymour Pierce Ltd., Non-Executive Director at China Medstar Ltd., Independent Director at Helius Medical Technologies, Inc., and Non-Executive Director at Faron Pharmaceuticals Oy, Navamedic ASA, Destiny Pharma Plc, Biodexa Pharmaceuticals Plc, and Acticor Biotech SAS.
He was also an Independent Non-Executive Director & GM at China Medical System Holdings Ltd.
and a Partner at Northland Bancorp, Inc. Additionally, he worked as a Senior Manager at Reabourne Technology Investment Management Ltd.
and as a Portfolio Manager at Close Asset Management (UK) Ltd.
Dr. Peng received his undergraduate and graduate degrees from Hunan University of Chinese Medicine and his doctorate from UCL Medical School.
Aktive Positionen von Huai Zheng Peng
| Unternehmen | Position | Beginn |
|---|---|---|
Blueberry Therapeutics Ltd.
 Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
A&B (HK) Co. Ltd.
 A&B (HK) Co. Ltd. Electronic Equipment/InstrumentsElectronic Technology A & B (HK) Co. Ltd. is a Chinese company that manufactures and distributes portable neuro-modulation stimulator devices. The private company is based in Hong Kong, Hong Kong. The CEO of the company is Huai Zheng Peng. | Vorstandsvorsitzender | - |
| Cambridge United China Collaborations Ltd. | Direktor/Vorstandsmitglied | - |
| China Medical Venture Investment Hk Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Huai Zheng Peng
| Unternehmen | Position | Ende |
|---|---|---|
| DESTINY PHARMA PLC | Direktor/Vorstandsmitglied | 01.06.2022 |
| HELIUS MEDICAL TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 01.05.2020 |
| BIODEXA PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 31.03.2020 |
Northland Bancorp, Inc.
 Northland Bancorp, Inc. Investment ManagersFinance Northland Bancorp, Inc. is a private equity firm located in Calgary, Alberta | Corporate Officer/Principal | 01.01.2012 |
| ░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Huai Zheng Peng
| Hunan University of Chinese Medicine | Graduate Degree |
| UCL Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 7 |
|---|---|
| HELIUS MEDICAL TECHNOLOGIES, INC. | Health Technology |
| FARON PHARMACEUTICALS OY | Health Technology |
| NAVAMEDIC ASA | Distribution Services |
| CHINA MEDICAL SYSTEM HOLDINGS LIMITED | Health Technology |
| DESTINY PHARMA PLC | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| ACTICOR BIOTECH SAS | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Seymour Pierce Ltd.
 Seymour Pierce Ltd. Investment Banks/BrokersFinance Seymour Pierce Ltd. (SP) is an independent Great Britain-based brokerage firm which was established in 1998. SP advises growing privately-owned businesses and publicly quoted UK companies, with a focus on AIM-listed companies. They provide stockbroking, corporate finance, private equity and M&A advisory services and specialize in raising funds for small- and medium-sized UK companies, either facilitating private equity investing or issuing securities. The firm provides sellside analysis to asset managers in Great Britain and internationally, including fund managers, hedge funds and private equity firms. Their research covers a range of sectors including retail, real estate, healthcare, media and entertainment, resources, software, telecommunications, financials, business services and special situations. SP also advises private clients and provides administrative support. They manage equity portfolios on a discretionary basis and provide equity trading accounts, both advisory and execution-only. | Finance |
China Medstar Ltd.
 China Medstar Ltd. Medical DistributorsDistribution Services China Medstar Ltd. supplies and leases radiotherapy equipment for cancer treatment. The company have sixteen operational centers, ten radiotherapy, two nuclear medicine examine (including ECT and PET-CT) and MR, and one HIFU and ophthalmic center. The company was established in 2003 and is headquartered in Beijing, China. | Distribution Services |
| Reabourne Technology Investment Management Ltd. | |
Close Asset Management (UK) Ltd.
 Close Asset Management (UK) Ltd. Investment ManagersFinance Close Asset Management (UK) Ltd., doing business as Close Brothers Asset Management (CBAM), is an investment management firm headquartered in London, UK. The firm is a subsidiary of Close Asset Management Holdings Ltd., itself a subsidiary of Close Brothers Group Plc (LON: CBG). The firm was formerly known as Close Investments Ltd. in 1994 and changed into their current name when Close Brothers Investment, Close Investment, Close Finsbury Asset Management, and Reabourne Technology Investment Management were reorganized into a single legal entity in 2009. CBAM provides a wide variety of financial advisory and investment management services to UK and international intermediaries, private individuals, and institutions such as pension funds. They also manage discretionary portfolios as well as a diverse range of investment products. | Finance |
Northland Bancorp, Inc.
Northland Bancorp, Inc. Investment ManagersFinance Northland Bancorp, Inc. is a private equity firm located in Calgary, Alberta | Finance |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Health Technology |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
A&B (HK) Co. Ltd.
A&B (HK) Co. Ltd. Electronic Equipment/InstrumentsElectronic Technology A & B (HK) Co. Ltd. is a Chinese company that manufactures and distributes portable neuro-modulation stimulator devices. The private company is based in Hong Kong, Hong Kong. The CEO of the company is Huai Zheng Peng. | Electronic Technology |
| China Medical Venture Investment Hk Ltd. | |
| Cambridge United China Collaborations Ltd. |
